Improvement of a patient with stuttering on levetiracetam

Neurology

Volumn 59, Issue 8, 2002, Pages 1288-

  Paola Canevini, Maria ^a   Chifari, Rosanna ^a   Piazzini, Ada ^a  

^a SAN PAOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; TOPIRAMATE; VALPROIC ACID;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; HUMAN; INTRACTABLE EPILEPSY; PRIORITY JOURNAL; STUTTERING;

EID: 0037159202     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000032104.06944.CD     Document Type: Article

References (7)

1. Market KE, Montague JC. Acquired stuttering. J Fluency Disord 1990;15:21-33.
2. Brady JP. The pharmacology of stuttering: a critical review. Am J Psychiatry 1991;148:1309-1316.
3. Packman A, Onslow M, Menzies R. Novel speech patterns and the treatment of stuttering. Disabil Rehabil 2000;22:65-79.
4. Gambardella A, Zappia M, Valentino P, et al. Action palatal tremor in patient with primary intestinal lymphoma. Move Disord 1997;12:794-797.
5. Rosenfield DB. Do stutters have different brains?. Neurology 2001;57:171-172.
6. Foundas AL, Bollich AM, Corey DM, Hureley M, Heilman KM. Anomalous anatomy of speech-language areas in adults with persistent developmental stuttering. Neurology 2001;57:207-215.
7. Kesser J, Thiel A, Karbe H, Heiss WD. Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients. Stroke 2000;31:2112.